Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)
Condition: Locally Advanced Cervical Cancer Interventions: Biological: Durvalumab; Drug: Cisplatin; Drug: Carboplatin; Radiation: external beam radiation therapy (EBRT) + brachytherapy Sponsor: AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Brachytherapy | Cancer | Cancer & Oncology | Cervical Cancer | External Beam Therapy | Radiation Therapy | Study | Women